Endo (NDOI) Insider Ownership : 0.00 % (As of Apr. 15, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Endo Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Endo's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Endo's Institutional Ownership is 1.11%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Endo's Float Percentage Of Total Shares Outstanding is 69.57%.

Endo Insider Ownership Historical Data

The historical data trend for Endo's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Insider Ownership Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Insider Ownership

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Insider Ownership	Get a 7-Day Free Trial			-	-	-	-	-

Endo Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.